Literature DB >> 17489576

Current and emerging targets to treat neuropathic pain.

John A Butera1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17489576     DOI： 10.1021/jm061015w

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  8 in total

1.  Design and assessment of a potent sodium channel blocking derivative of mexiletine for minimizing experimental neuropathic pain in several rat models.

Authors:  Robert M Weston; Kamani R Subasinghe; Vasiliki Staikopoulos; Bevyn Jarrott
Journal:  Neurochem Res       Date:  2009-06-06       Impact factor: 3.996

2.  Design, synthesis and biological activity evaluation of arylpiperazine derivatives for the treatment of neuropathic pain.

Authors:  Yin Chen; Guan Wang; Xiangqing Xu; Bi-Feng Liu; Jianqi Li; Guisen Zhang
Journal:  Molecules       Date:  2011-07-07       Impact factor: 4.411

3.  Incarvillateine produces antinociceptive and motor suppressive effects via adenosine receptor activation.

Authors:  Jinwoo Kim; Diane M Bogdan; Matthew W Elmes; Monaf Awwa; Su Yan; Joyce Che; Garam Lee; Dale G Deutsch; Robert C Rizzo; Martin Kaczocha; Iwao Ojima
Journal:  PLoS One       Date:  2019-06-25       Impact factor: 3.240

4.  Synaptotagmin 1 Is Involved in Neuropathic Pain and Electroacupuncture-Mediated Analgesic Effect.

Authors:  Juan Wan; Sha Nan; Jingjing Liu; Mingxing Ding; Hongmei Zhu; Chuanguang Suo; Zhuole Wang; Manli Hu; Dehai Wang; Yi Ding
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

5.  An Investigation of the Molecular Mechanisms Underlying the Analgesic Effect of Jakyak-Gamcho Decoction: A Network Pharmacology Study.

Authors:  Ho-Sung Lee; In-Hee Lee; Kyungrae Kang; Sang-In Park; Tae-Wook Kwon; Dae-Yeon Lee
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-01       Impact factor: 2.629

Review 6.  The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives.

Authors:  Katarzyna Ciapała; Joanna Mika; Ewelina Rojewska
Journal:  Int J Mol Sci       Date:  2021-10-13       Impact factor: 5.923

7.  ω-Conotoxin GVIA mimetics that bind and inhibit neuronal Ca(v)2.2 ion channels.

Authors:  Charlotte Elisabet Tranberg; Aijun Yang; Irina Vetter; Jeffrey R McArthur; Jonathan B Baell; Richard J Lewis; Kellie L Tuck; Peter J Duggan
Journal:  Mar Drugs       Date:  2012-10-22       Impact factor: 6.085

8.  Mechanisms of electroacupuncture-induced analgesia on neuropathic pain in animal model.

Authors:  Woojin Kim; Sun Kwang Kim; Byung-Il Min
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-31       Impact factor: 2.629
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.